openFDA text is shown for search and cross-checking; DailyMed SPL is canonical.
Warnings sections page 1 of 1 · 1 matching rows.
warnings
WARNINGS Oxybutynin chloride, when administered in the presence of high environmental temperature, can cause heat prostration (fever and heat stroke due to decreased sweating). Diarrhea may be an early symptom of incomplete intestinal obstruction, especially in patients with ileostomy or colostomy. In this instance treatment with oxybutynin chloride would be inappropriate and possibly harmful. Oxybutynin chloride may produce drowsiness or blurred vision. The patient should be cautioned regarding activities requiring mental alertness such as operating a motor vehicle or other machinery or performing hazardous work while taking this drug. Alcohol or other sedative drugs may enhance the drowsiness caused by oxybutynin chloride.
ADVERSE REACTIONS Following administration of oxybutynin chloride, the symptoms that can be associated with the use of other anticholinergic drugs may occur: Cardiovascular: Palpitations, tachycardia, vasodilatation. Dermatologic: Decreased sweating, rash. Gastrointestinal/ Genitourinary: Constipation, decreased gastrointestinal motility, dry mouth, nausea, urinary hesitance and retention. Nervous System: Asthenia, dizziness, drowsiness, hallucinations, insomnia, restlessness. Ophthalmic : Amblyopia, cycloplegia, decreased lacrimation, mydriasis. Other: Impotence, suppression of lactation.